Adagio Medical Reports Successful Pivotal Outcomes for vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. has reported compelling six-month clinical outcomes from its pivotal FULCRUM-VT Investigational Device Exemption (IDE) trial, marking a significant milestone in the advancement of catheter ablation…
Dental Care Alliance Unveils Strategic Transaction to Bolster Financial Stability and Drive Long-Term Growth Dental Care Alliance (DCA), one of the largest dental support organizations in the United States, has announced a major financial restructuring agreement with its existing lender…
HealthPartners Highlights Ongoing Progress, Key Priorities, and Future Actions to Advance Simpler, More Affordable Health Care Amid a persistent rise in both medical and pharmacy costs, HealthPartners is stepping up its efforts to make health care more accessible, understandable and…
Bausch + Lomb Publishes Review on B Vitamins and Their Role in Reducing Risk and Progression of Age-Related Macular Degeneration Bausch + Lomb Corporation has announced the publication of a major scientific narrative review in the peer-reviewed journal Ophthalmology and…
AbbVie Chooses North Carolina as Site for $1.4 Billion Advanced Manufacturing Facility AbbVie has unveiled an ambitious new chapter in its long-term growth strategy with the announcement of a $1.4 billion investment to establish a cutting-edge pharmaceutical manufacturing campus in…
Kennel Connection Forms Exclusive Partnership with Petwealth to Deliver Clinical-Grade Pet Health Screening Across Pet Care Facilities Nationwide Kennel Connection, a leading provider of pet care facility management software and part of the 100GROUP portfolio, has announced a significant advancement…
Flatiron Health Highlights 18 Accepted Studies Leveraging Real-World Data for Presentation at ISPOR 2026 Flatiron Health has announced a significant presence at the ISPOR Annual Meeting 2026, taking place from May 17 to May 20, 2026, in Philadelphia. The company’s…
Vyome Showcases Transformative Phase 2 Clinical Results for VT-1953 at AACR 2026 Vyome Holdings, Inc. (Nasdaq: HIND), a clinical-stage biotechnology company focused on developing innovative therapies for underserved conditions, has unveiled comprehensive Phase 2 investigator-initiated study results along with supporting…
Veristat to Acquire Certara’s Regulatory Affairs and Medical Writing Business Veristat, a science-first, full-service clinical research organization (CRO) and consultancy specializing in advancing complex therapies from early development through regulatory submission, has announced its intended acquisition of Certara’s Regulatory and…
CareDx to Present Over 50 Abstracts, Including 16 Oral Presentations, at ISHLT 46th Annual Meeting CareDx, a leading precision medicine organization dedicated to advancing transplant care through innovative diagnostic and digital health solutions, has announced its participation in the International…
Donor Funding Drives $15M Initiative Supporting 62 Researchers Focused on Alzheimer’s, Macular Degeneration, and Glaucoma The BrightFocus Foundation has announced a major new investment of $15.2 million in research grants aimed at advancing scientific discovery in three of the most…
U.S. Food and Drug Administration Accepts Filing for Genentech’s Gazyva Targeting the Most Prevalent Form of Lupus Genentech, a member of the Roche Group, has announced a major regulatory milestone in its efforts to expand treatment options for autoimmune diseases.…